Skip to main content
Article thumbnail
Location of Repository

Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis

By Naheed Aryaeian, Farhad Shahram, Mahmoud Djalali, Mohammad R Eshragian, Abolghasem Djazayeri, Abdolfatah Sarrafnejad, Nasim Naderi, Maryam Chamari, Fariha Fatehi and Mahnaz Zarei

Abstract

The aim of this study was to assess the impact of conjugated linoleic acids (CLAs), vitamin E, and combination of these nutrients on serum lipid profiles and blood pressure (BP) in patients with active rheumatoid arthritis (RA). In a randomized, double-blind, placebo-controlled trial, 87 patients with active RA were divided into four groups receiving one of the following daily supplements for three months: Group C: CLAs 2.5 g equivalent to 2 g mixture of cis 9-trans 11 and trans 10-cis12 CLAs in a rate of 50/50; Group E: vitamin E: 400 mg; Group CE: CLAs and vitamin E at above doses: Group P: placebo. After supplementation, SBP levels decreased significantly in the group C in comparison with groups E and P and mean arterial pressure reduced significantly in groups C and CE. There weren’t significant differences in the levels of prostaglandin E2 (PGE2), triglycerides, cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), LDL/HDL, cholesterol/HDL, fasting blood sugar, C-reactive protein (CRP), arylestrase activity, platelet count and body mass index between groups. CRP dropped nonsignificantly in groups P, C, E and CE (19%, 24%, 55%, and 39%, respectively). Erythrocytes sedimentation rate levels decreased in groups C, E and CE (P ≤ 0.05, P ≤ 0.05, P ≤ 0.001, respectively). It is concluded that supplementation of CLAs decreased BP and vitamin E decreased CRP. Therefore cosupplementation of CLAs and vitamin E might be profitable for heart disease prevention in RA patients

Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2663461
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2005). A cis-9, trans-11-conjugated linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. Am J Physiol Heart Circ Physiol,
    2. (2001). A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis.
    3. (2006). Alpha tocopherol supplementation elevates plasma apolipoprotein A1 isoforms in normal healthy subjects.
    4. (2005). Alpha-tocopherol: roles in prevention and therapy of human disease.
    5. (2000). An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters.
    6. (2003). Antioxidant effect of conjugated linoleic acid and vitamin A during non enzymatic lipid peroxidation of rat liver microsomes and mitochondria. Mol Cell Biochem,
    7. (2007). Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample. Arthritis Rheum,
    8. (1999). Antiplatelet effects of conjugated linoleic acid isomers.
    9. (2007). Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag,
    10. (1999). Atherosclerosis and conjugated linoleic acid.
    11. (2007). Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for infl ammation. Arthritis Res Ther,
    12. (2006). Biological effects of conjugated linoleic acids in health and disease.
    13. (2006). Calcium and conjugated linoleic acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes. Am J Hypertens, 9(Suppl 4):381–7J.
    14. (2005). Calcium plus linoleic acid therapy for pregnancy-induced hypertension.
    15. (1999). CLAs and PPARgamma activation.
    16. (2001). Comparison of antioxidant effi cacy of vitamin E, vitamin C, vitamin A and fruits in coronary heart disease: a controlled trial.
    17. (2001). Conjugated linoleic acid (CLAs) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial.
    18. (1999). Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat.
    19. (1994). Conjugated linoleic acid and therosclerosis in rabbits.
    20. (2003). Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats.
    21. (2000). Conjugated linoleic acid induces lipid peroxidation in humans.
    22. (2000). Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity.
    23. (1999). Conjugated linoleic acid is a potent naturally occuring ligand and activator of PPARa.
    24. (2001). Conjugated linoleic acid isomers have differential effects on triglyceride secretion
    25. (2000). Conjugated linoleic acid reduces early aortic atherosclerosis greater than linoleic acid in hypercholesterolemic hamsters. Nutr Res,
    26. (2001). Conjugated linoleic acid supplementation in humans metabolic effects.
    27. (2000). Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure.
    28. (2000). Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes,
    29. (2001). Conjugated linoleic acid: A review. Altern Med Rev,
    30. (2003). Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
    31. (2004). Decreased aortic early atherosclerosis and associated risk factors in hypercholesterolemic hamsters fed a high- or mid-oleic acid oil compared to a high-linoleic acid oil.
    32. (1996). Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women.
    33. (2004). Dietary conjugated linoleic acid and insulin sensitivity and resistance in rodent models.
    34. (1998). Dietary conjugated linoleic acid normalises impared glucose tolerance in the Zucker diabetic fatty fa/fa rat.
    35. (1998). Dietary conjugated linoleic acid normalizes impaired glucose tolerance in Zucker diabetic fatty fa/fa rat.
    36. (2005). Dietary conjugated linoleic acid reduces lipid peroxidation by increasing oxidative stability in rats.
    37. (1997). Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters.
    38. (1999). Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model.
    39. (2006). Diets rich in conjugated linoleic acid and vaccenic acid have no effect on blood pressure and isobaric arterial elasticity in healthy young men.
    40. (2002). Differential responses of hamsters and rats fed hig-fat or low-fat diets supplemented with conjugated linoleic acid. Nutr Res,
    41. (2005). Effect of α-tocopherol supplementation on blood pressure and lipidic profi le in streptozotocininduced diabetes mellitus in spontaneously hypertensive rats. Clinica Chimica Acta,
    42. (2008). Effects of fish oil and conjugated linoleic acids on expression of target genes of PPARa and sterol regulatory element-binding proteins in the liver of laying hens.
    43. (2007). Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins.
    44. Health Syst Pharm,
    45. (2000). High dietary levels of conjugated linoleic acid mixture alter hepatic glycerophospholipid CLAss profi le and cholesterol-carrying serum lipoproteins of rats.
    46. (1989). High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies.
    47. (1993). Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C.
    48. (2000). Infl uence of conjugated linoleic acid (CLAs) on establishment and progression of atherosclerosis in rabbits.
    49. (2002). Isomer-dependent metabolic effects of conjugated linoleic acid: insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha.
    50. (2004). Isomer-specifi c effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitor. Clin Sci (Lond),
    51. (2005). Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the blood lipid profi le and body composition of overweight and obese men.
    52. (2004). Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans.
    53. (2003). Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler Thromb Vasc Biol,
    54. (2007). Phase 2 enzyme induction by conjugated linoleic acid improves lupus-associated oxidative stress. Free Radic Biol Med,
    55. (1999). PPAR gamma: an essential regulator of adipogenesis and modulator of fat cell function.
    56. (1996). Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS).
    57. (2003). Regression of pre established atherosclerosis in the apoE-/- mouse by conjugated linoleic acid. Biochem Soc Trans,
    58. (1999). Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol.
    59. (2008). Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology,
    60. (2006). Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice.
    61. (1986). Simultaneous measurement of retinol and α-tocopherol in human serum by high-performance liquid chromatography with ultraviolet detection.
    62. (1999). Species differences in the metabolism and regulation of gene expression by conjugated linoleic acid. Nutr Rev,
    63. (2007). Supplementation with commercial mixtures of conjugated linoleic acid in association with vitamin E and the process of lipid autoxidation in rats.
    64. (1988). The American Rheumatoid Association
    65. (2000). The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1.
    66. (2001). The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids, 36:229–36.Vascular Health and Risk Management 2008:4(6) 1431 Lipid profi les and blood pressure of Iranian adults with rheumatoid arthritis
    67. (2002). The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects.
    68. (2007). The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    69. (1980). The Essentials in Pressure Monitoring.
    70. (2001). The growth inhibitory effect of conjugated linoleic acid on a human hepatoma cell line, HepG2, is induced by a change in fatty acid metabolism, but not the facilitation of lipid peroxidation in the cells. Biochim Biophys Acta,
    71. (2003). trans, 12 cis isomer of conjugated linoleic acid suppresses the development of hypertension in Otsuka Long–Evans Tokushima fatty rats.
    72. (2002). Treatment with dietary trans10 cis12 conjugated linoleic acid causes isomer-specifi c insulin resistance in obese men with the metabolic syndrome. Diabetes Care,
    73. (2002). Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol,
    74. (2003). Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review.
    75. (1998). Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations. Circ Res,
    76. (1993). Vitamin E consumption and the risk of coronary disease in women.
    77. (1993). Vitamin E consumption and the risk of coronary heart disease in men.
    78. (2007). Vitamin E dietary supplementation signifi cantly affects multiple risk factors for cardiovascular disease in baboons.
    79. (2005). Vitamin E supplementation alters HDL-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: comparison with probucol.
    80. (2005). Vitamin E, oxidative stress, and infl ammation. Annu Rev Nutr,

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.